Introduction to Li-Campeau Syndrome and UBR7 Genetics

Li-Campeau syndrome is an ultrarare autosomal recessive neurodevelopmental disorder that stems from biallelic pathogenic alterations in the UBR7 gene. Historically, geneticists have associated this condition with profound developmental delay, intellectual disability, early-onset epilepsy, congenital hypothyroidism, ptosis, and distinct facial dysmorphisms. In addition, many affected children exhibit structural cardiac anomalies and genital malformations. Until recently, global literature documented fewer than ten affected individuals worldwide. However, recent clinical investigations continue to redefine our baseline understanding of this complex condition. A newly documented case involving an 18-year-old female presents a unique homozygous deletion encompassing exon 7 of UBR7. Furthermore, this discovery represents the very first single-exon deletion reported in this gene. The patient demonstrated classic dysmorphic facial features, bilateral ptosis, congenital hypothyroidism, and intellectual disability. Nevertheless, she also presented with unusual features such as stereotypic hand movements, attention-deficit/hyperactivity disorder, hepatosplenomegaly, and toenail hypoplasia. Consequently, this remarkable finding broadens both the known clinical manifestations and the mutational spectrum of this severe hereditary condition.

Phenotypic Variability and Mild Trajectories in Li-Campeau Syndrome

Historically, clinicians recognized Li-Campeau syndrome primarily through severe, unremitting global developmental delays that presented during early infancy. In striking contrast, this newly evaluated patient achieved age-appropriate early motor and language milestones. Therefore, her trajectory represents the mildest early developmental presentation recorded in medical literature to date. She walked independently and developed functional communication skills during her early childhood years. However, cognitive challenges and behavioral difficulties emerged as she progressed into adolescence. Specifically, clinicians identified attention-deficit/hyperactivity disorder alongside stereotypic hand mannerisms that closely mimic other neurodevelopmental syndromes. In addition, the presence of hepatosplenomegaly and toenail hypoplasia illustrates an expanded somatic phenotype that previous reports overlooked. Because rare recessive disorders often display variable expressivity, clinicians must recognize that milder infant presentations can still harbor severe underlying genomic variants. Consequently, developmental pediatricians should maintain high vigilance whenever syndromic dysmorphisms coexist with endocrine disruptions, even when gross motor development initially appears intact.

Molecular Mechanisms of UBR7 and Ubiquitin Ligase Dysfunction

The UBR7 gene encodes ubiquitin protein ligase E3 component n-recognin 7, which plays a central role in protein homeostasis. Specifically, UBR7 facilitates targeted substrate recognition and ubiquitination, guiding aberrant or transient proteins toward proteasomal degradation. In addition, UBR7 influences fundamental cellular processes, including chromatin regulation, transcriptional control, and histone modification. When biallelic variants disrupt UBR7 function, abnormal protein turnover impairs normal embryonic organogenesis and neural circuit maturation. Consequently, cells in the developing central nervous system and endocrine organs suffer metabolic and structural stress. Previous investigations identified missense, nonsense, and frameshift mutations that lead to loss of function. However, the discovery of a homozygous single-exon deletion encompassing exon 7 confirms that targeted intragenic deletions also eliminate vital enzymatic function. Exon 7 encodes critical structural elements of the ligase domain. Thus, the deletion prevents normal catalytic assembly. Furthermore, these molecular disruptions explain why multisystem features, such as thyroid dysgenesis and craniofacial anomalies, recur consistently across unrelated kindreds.

Diagnostic Utility of Next-Generation Sequencing and CNV Analysis

Establishing a definitive molecular diagnosis in ultrarare pediatric syndromes presents substantial challenges for modern clinicians. Standard chromosomal microarrays often lack the probe density required to detect tiny intragenic single-exon losses. Meanwhile, routine exome sequencing pipelines frequently miss structural variations if they only evaluate single-nucleotide variants. Fortunately, bioinformatic advances in next-generation sequencing now allow accurate copy-number variant calling directly from exome sequencing datasets. In this patient, high-resolution exome-based copy-number variant analysis readily detected the homozygous exon 7 deletion in UBR7. Therefore, implementing copy-number analysis within routine sequencing workflows significantly increases diagnostic yield for complex congenital conditions. In addition, timely molecular confirmation prevents extensive, unnecessary diagnostic investigations. Molecular clarity also empowers clinical geneticists to deliver accurate recurrence risk assessments to parents during preconception counseling. Ultimately, genomic testing provides an indispensable cornerstone for modern rare disease management, particularly when patients manifest atypical or milder developmental milestones.

Multidisciplinary Clinical Management and Pediatric Care Strategies

Managing complex neurodevelopmental disorders requires cohesive coordination across diverse medical and pediatric subspecialties. Because Li-Campeau syndrome involves multiple organ systems, proactive surveillance remains essential throughout childhood and adult life. First, pediatric endocrinologists must evaluate thyroid function immediately, initiating levothyroxine replacement therapy promptly to protect neurological development. Second, pediatric neurologists should monitor patients closely for clinical seizures and perform baseline electroencephalography whenever suspicious episodes occur. In addition, developmental specialists must provide ongoing behavioral assessments to identify attention-deficit disorders, autism spectrum features, and stereotypic hand movements early. Consequently, individualized behavioral therapies and educational interventions can improve long-term independence and cognitive outcomes. Meanwhile, pediatric cardiologists should perform comprehensive echocardiography to rule out structural cardiac defects. Pediatric ophthalmologists must also assess ptosis to prevent visual axis occlusion and subsequent amblyopia. Thus, integrated, long-term multidisciplinary care pathways optimize overall systemic health and functional quality of life for every affected individual.

Frequently Asked Questions

What is the primary genetic cause of Li-Campeau syndrome?

Li-Campeau syndrome develops due to biallelic loss-of-function variants in the UBR7 gene on chromosome 14. This gene encodes an essential ubiquitin ligase component involved in protein degradation and cellular regulation. Pathogenic variants disrupt normal protein turnover during early embryonic development. Consequently, affected individuals experience multisystem symptoms, including cognitive impairment, facial dysmorphism, ptosis, and variable congenital structural malformations.

How does this newly identified single-exon deletion expand clinical knowledge?

The single-exon deletion in UBR7 proves that small intragenic copy-number variants cause Li-Campeau syndrome alongside conventional sequence mutations. Clinically, this patient demonstrated normal early motor and language milestones, which reveals a much broader developmental spectrum than previously recognized. Furthermore, novel manifestations such as toenail hypoplasia, hepatosplenomegaly, and stereotypic hand movements broaden the diagnostic criteria for treating clinicians worldwide.

Why is comprehensive copy-number variant calling essential during genetic evaluation?

Standard exome sequencing pipelines frequently focus exclusively on single-nucleotide substitutions and small insertions or deletions. Consequently, clinicians may overlook single-exon deletions without specialized copy-number bioinformatic algorithms. Employing bioinformatic tools capable of detecting small intragenic structural alterations directly from sequencing data substantially enhances overall diagnostic accuracy, thereby preventing prolonged diagnostic odysseys for affected pediatric patients and their families.

Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.

References

Duzenli T et al. Expanding the Genotypic and Phenotypic Spectrum of Li-Campeau Syndrome: A Homozygous Single-Exon Deletion in UBR7. Am J Med Genet A. 2026 Oct 19. doi: 10.1002/ajmg.a.70342. PMID: 42897110.

Li B et al. Biallelic UBR7 variants cause Li-Campeau syndrome characterized by neurodevelopmental delay, congenital heart disease, and facial dysmorphism. Am J Hum Genet. 2021;108(7):1314-1323.

Richards S et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-424.